FORMULATION AND EVALUATION OF NIOSOMAL GEL OF AZELAIC ACID FOR ANTIACNE ACTIVITY

VIVEK KASHYAP; ANJNA RANI

doi:10.22159/ijap.2023v15i5.48593

Authors

VIVEK KASHYAP Noida Institute of Engineering and Technology (Pharmacy Institute), 19 Knowledge Park-II, Institutional Area, Greater Noida-201306, Uttar Pradesh, India
ANJNA RANI Noida Institute of Engineering and Technology (Pharmacy Institute), 19 Knowledge Park-II, Institutional Area, Greater Noida-201306, Uttar Pradesh, India https://orcid.org/0000-0002-7575-7580

DOI:

https://doi.org/10.22159/ijap.2023v15i5.48593

Keywords:

Azelaic acid, Niosomes, Thin film hydration, Topical gel, Sustained release, Entrapment efficiency

Abstract

Objective: This study aimed to develop niosomes loaded with azelaic acid (AA) to administer in gel form. The primary objective was to achieve controlled and sustained release of the drug while minimizing potential side effects.

Methods: Niosomes were fabricated using a combination of various non-ionic surfactants and cholesterol through the application of thin film hydration technique. Furthermore, the processing parameters were optimized and drug excipient compatibility study was conducted using FTIR spectroscopy. The formulations were extensively characterized in terms of entrapment efficiency, particle size, shape, and in vitro release. Subsequently, the improved niosomal dispersions were employed to formulate gels, which underwent analysis to evaluate their visual properties, pH, and rheological behavior. Stability study was also conducted.

Results: Total 15 formulations were prepared, out of which 3 formulations F3, F9 and F15 were found to exhibit maximum entrapment efficiency. These formulation were having particle size 260.1 nm, 272.3 nm and 226.3 nm respectively. In vitro drug release was found to be maximum in F9 formulation. The release was found to be dose-dependent across all formulations, with regression values between 0.97 and 0.99, confirming first-order release kinetics. FTIR spectra indicated the absence of any drug-cholesterol-nonionic surfactant interaction in the formulation. The niosomal gel formulations exhibited optimal performance when stored within the temperature range of 4 to 8 °C.

Conclusion: This investigation demonstrates the utility of the thin film hydration technique in effectively incorporating poorly water-soluble medications such as azelaic Acid (AA) into niosomes, resulting in high entrapment efficiency. These findings suggest that niosomes containing AA, when topically applied as a gel, have the potential to be an efficacious treatment for acne.

Downloads

Download data is not yet available.

References

Fox L, Csongradi C, Aucamp M, du Plessis J, Gerber M. Treatment modalities for acne. Molecules. 2016 Aug 13;21(8):1063. doi: 10.3390/molecules21081063, PMID 27529209, PMCID PMC6273829.

Barros BS, Zaenglein AL. The use of cosmeceuticals in acne: help or hoax? Am J Clin Dermatol. 2017 Apr;18(2):159-63. doi: 10.1007/s40257-016-0249-6, PMID 28063095.

Sahni K, Singh S, Dogra S. Newer topical treatments in skin and nail dermatophyte infections. Indian Dermatol Online J. 2018 May-Jun;9(3):149-58. doi: 10.4103/idoj.IDOJ_281_17. PMID 29854633, PMCID PMC5956860.

Walocko FM, Eber AE, Keri JE, Al-Harbi MA, Nouri K. The role of nicotinamide in acne treatment. Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12481. PMID 28220628.

Vyas A, Kumar Sonker A, Gidwani B. Carrier-based drug delivery system for treatment of acne. Scientific World Journal. 2014 Feb 9;2014:276260. doi: 10.1155/2014/276260, PMID 24688376, PMCID PMC3934386.

Shahmoradi Z, Iraji F, Siadat AH, Ghorbaini A. Comparison of topical 5% Nicotinamid gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: a double-blinded randomized clinical trial. J Res Med Sci. 2013 Feb;18(2):115-7. PMID 23914212, PMCID PMC3724370.

Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. Am J Clin Dermatol. 2018 Aug;19(4):489-503. doi: 10.1007/s40257-017-0333-6, PMID 29222629.

Taherzade SD, Rojas S, Soleimannejad J, Horcajada P. Combined cutaneous therapy using biocompatible metal-organic frameworks. Nanomaterials (Basel). 2020 Nov 25;10(12):2296. doi: 10.3390/nano10122296, PMID 33255580, PMCID PMC7760737.

Hu S, Laughter MR, Anderson JB, Sadeghpour M. Emerging topical therapies to treat pigmentary disorders: an evidence-based approach. J Dermatolog Treat. 2022 Jun;33(4):1931-7. doi: 10.1080/09546634.2021.1940811. PMID 34114938.

Babbush KM, Babbush RA, Khachemoune A. Treatment of melasma: a review of less commonly used antioxidants. Int J Dermatol. 2021 Feb;60(2):166-73. doi: 10.1111/ijd.15133. PMID 32815582.

Hekmatpou D, Mehrabi F, Rahzani K, Aminiyan A. The effect of aloe vera clinical trials on prevention and healing of skin wound: a systematic review. Iran J Med Sci. 2019 Jan;44(1):1-9. PMID 30666070, PMCID PMC6330525.

Liu H, Yu H, Xia J, Liu L, Liu GJ, Sang H. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. Cochrane Database Syst Rev. 2020;5(5):CD011368. doi: 10.1002/14651858.CD011368.pub2. PMID 32356369.

Li N, Su Q, Tan F, Zhang J. Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid. Int J Pharm. 2010 Mar 15;387(1-2):167-71. doi: 10.1016/j.ijpharm.2009.12.025. PMID 20025951.

MS, Buddha S, Kumari PVK, Rao YS. Proniosomes: a vesicular drug delivery system. Int J Curr Pharm Sci. 2021 Nov 15;13(6):32-6.